CCAAT/enhancer binding protein beta (C/EBPβ) isoform balance as a regulator of epithelial-mesenchymal transition in mouse mammary epithelial cells

Experimental Cell Research

Volumn 327, Issue 1, 2014, Pages 146-155

  Miura, Yuka ^a   Hagiwara, Natsumi ^a   Radisky, Derek C ^b   Hirai, Yohei ^a  

^a KWANSEI GAKUIN UNIVERSITY   (Japan)

^b MAYO CLINIC   (United States)

Author keywords

Basement membrane; C EBP ; EMT; Epimorphin; Mammary epithelia; MET

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; GELATINASE A; KERATIN; LAMININ; MESSENGER RNA; P CADHERIN; SYNTAXIN 2; TETRACYCLINE; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN;

ADENOMA CELL LINE; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BREAST EPITHELIUM; CELL FUNCTION; CELL PROLIFERATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; MICROENVIRONMENT; MORPHOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; TISSUE CULTURE; TRANSLATION INITIATION; UPREGULATION;

BASEMENT MEMBRANE; C/EBPΒ; EMT; EPIMORPHIN; MAMMARY EPITHELIA; MET;

ANIMALS; BASEMENT MEMBRANE; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; COLLAGEN; DRUG COMBINATIONS; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; LAMININ; MAMMARY GLANDS, ANIMAL; MEMBRANE GLYCOPROTEINS; MICE; PROTEIN ISOFORMS; PROTEOGLYCANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84906938853     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.05.019     Document Type: Article

References (50)

1. Hugo H., Ackland M.L., Blick T., Lawrence M.G., Clements J.A., Williams E.D., Thompson E.W. Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. J. Cell. physiol. 2007, 213:374-383.
2. Tsai J.H., Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013, 27:2192-2206.
3. Asiedu M.K., Ingle J.N., Behrens M.D., Radisky D.C., Knutson K.L. TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res. 2011, 71:4707-4719.
4. Radisky D.C., Bissell M.J. NF-kappaB links oestrogen receptor signalling and EMT. Nat. Cell Biol. 2007, 9:361-363.
5. Radisky D.C., Levy D.D., Littlepage L.E., Liu H., Nelson C.M., Fata J.E., Leake D., Godden E.L., Albertson D.G., Nieto M.A., Werb Z., Bissell M.J. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436:123-127.
6. Albergaria A., Resende C., Nobre A.R., Ribeiro A.S., Sousa B., Machado J.C., Seruca R., Paredes J., Schmitt F. CCAAT/enhancer binding protein beta (C/EBPbeta) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells. PLoS One 2013, 8:e55749.
7. Bundy L.M., Sealy L. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 2003, 22:869-883.
8. Robinson G.W., Johnson P.F., Hennighausen L., Sterneck E. The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev. 1998, 12:1907-1916.
9. Zahnow C.A. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev. Mol. Med. 2009, 11:e12.
10. Bascom J.L., Fata J.E., Hirai Y., Sternlicht M.D., Bissell M.J. Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma. Cancer Res. 2005, 65:8617-8621.
11. Bascom J.L., Radisky D.C., Koh E., Fata J.E., Lo A., Mori H., Roosta N., Hirai Y., Bissell M.J. Epimorphin is a novel regulator of the progesterone receptor isoform-a. Cancer Res. 2013, 73:5719-5729.
12. Hirai Y., Radisky D., Boudreau R., Simian M., Stevens M.E., Oka Y., Takebe K., Niwa S., Bissell M.J. Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbeta. J. Cell Biol. 2001, 153:785-794.
13. Yew K.H., Crow J., Hirst J., Pressetto Z., Godwin A.K. Epimorphin-induced MET sensitizes ovarian cancer cells to platinum. PLoS One 2013, 8:e72637.
14. Descombes P., Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991, 67:569-579.
15. Calkhoven C.F., Muller C., Leutz A. Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev. 2000, 14:1920-1932.
16. Park B.H., Kook S., Lee S., Jeong J.H., Brufsky A., Lee B.C. An isoform of C/EBPbeta, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration. J. Biol. Chem. 2013, 288:28656-28667.
17. Zahnow C.A., Cardiff R.D., Laucirica R., Medina D., Rosen J.M. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res. 2001, 61:261-269.
18. Baer M., Johnson P.F. Generation of truncated C/EBPbeta isoforms by in vitro proteolysis. J. Biol. Chem. 2000, 275:26582-26590.
19. Dearth L.R., Hutt J., Sattler A., Gigliotti A., DeWille J. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells. J. Cell. Biochem. 2001, 82:357-370.
20. Danielson K.G., Oborn C.J., Durban E.M., Butel J.S., Medina D. Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:3756-3760.
21. Roskelley C.D., Desprez P.Y., Bissell M.J. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:12378-12382.
22. Schmidhauser C., Bissell M.J., Myers C.A., Casperson G.F. Extracellular matrix and hormones transcriptionally regulate bovine beta-casein 5' sequences in stably transfected mouse mammary cells. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:9118-9122.
23. Nelson C.M., Khauv D., Bissell M.J., Radisky D.C. Change in cell shape is required for matrix metalloproteinase-induced epithelial-mesenchymal transition of mammary epithelial cells. J. Cell. Biochem. 2008, 105:25-33.
24. Lochter A., Galosy S., Muschler J., Freedman N., Werb Z., Bissell M.J. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 1997, 139:1861-1872.
25. Hirai Y., Lochter A., Galosy S., Koshida S., Niwa S., Bissell M.J. Epimorphin functions as a key morphoregulator for mammary epithelial cells. J. Cell Biol. 1998, 140:159-169.
26. Mamuya F.A., Duncan M.K. aV integrins and TGF-beta-induced EMT: a circle of regulation. J. Cell. Mol. Med. 2012, 16:445-455.
27. Wendt M.K., Tian M., Schiemann W.P. Deconstructing the mechanisms and consequences of TGF-beta-induced EMT during cancer progression. Cell Tissue Res. 2012, 347:85-101.
28. Okugawa Y., Hirai Y. Overexpression of extracellular epimorphin leads to impaired epidermal differentiation in HaCaT keratinocytes. J. Investig. Dermatol. 2008, 128:1884-1893.
29. Hagiwara N., Kadono N., Miyazaki T., Maekubo K., Hirai Y. Extracellular syntaxin4 triggers the differentiation program in teratocarcinoma F9 cells that impacts cell adhesion properties. Cell Tissue Res. 2013, 354:581-591.
30. Hirai Y., Nelson C.M., Yamazaki K., Takebe K., Przybylo J., Madden B., Radisky D.C. Non-classical export of epimorphin and its adhesion to {alpha}v-integrin in regulation of epithelial morphogenesis. J. Cell Sci. 2007, 120:2032-2043.
31. J. Rodriguez-Ubreva, E. Ballestar, Chromatin immunoprecipitation, Methods in Molecular Biology, vol. 1094, Humana Press, 2014, pp. 309-318.
32. Johansson J., Berg T., Kurzejamska E., Pang M.F., Tabor V., Jansson M., Roswall P., Pietras K., Sund M., Religa P., Fuxe J. MiR-155-mediated loss of C/EBPbeta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene 2013, 32:5614-5624.
33. Arnal-Estape A., Tarragona M., Morales M., Guiu M., Nadal C., Massague J., Gomis R.R. HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPss isoforms. Cancer Res. 2010, 70:9927-9936.
34. Gomis R.R., Alarcon C., Nadal C., Van Poznak C., Massague J. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 2006, 203-214.
35. Zahnow C.A., Younes P., Laucirica R., Rosen J.M. Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J. Natl. Cancer Inst. 1997, 89:1887-1891.
36. Seilmaier M., Hecht A., Guggemos W., Adorf D., Gehbauer G. Pancytopenia, hepatosplenomegaly and dry cough after breast cancer. Dtsch. Med. Wochenschr. 1946, 134(2009):1269-1273.
37. Klick D.E., Shadley J.D., Hines R.N. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins. Biochem. Pharmacol. 2008, 76:268-278.
38. Takayama K., Kawabata K., Nagamoto Y., Inamura M., Ohashi K., Okuno H., Yamaguchi T., Tashiro K., Sakurai F., Hayakawa T., Okano T., Furue M.K., Mizuguchi H. CCAAT/enhancer binding protein-mediated regulation of TGFbeta receptor 2 expression determines the hepatoblast fate decision. Development 2014, 141:91-100.
39. Radisky D.C., Stallings-Mann M., Hirai Y., Bissell M.J. Single proteins might have dual but related functions in intracellular and extracellular microenvironments. Nat. Rev. Mol. Cell Biol. 2009, 10:228-234.
40. Li H., Baldwin B.R., Zahnow C.A. LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis. Mol. Cancer 2011, 10:100.
41. Paredes J., Correia A.L., Ribeiro A.S., Albergaria A., Milanezi F., Schmitt F.C. P-cadherin expression in breast cancer: a review. Breast Cancer Res. 2007, 9:214.
42. Patel L.R., Curran T., Kerppola T.K. Energy transfer analysis of Fos-Jun dimerization and DNA binding. Proc. Nat. Acad. Sci. U.S.A. 1994, 91:7360-7364.
43. Williams S.C., Cantwell C.A., Johnson P.F. A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev. 1991, 5:1553-1567.
44. Welm A.L., Timchenko N.A., Darlington G.J. C/EBPalpha regulates generation of C/EBPbeta isoforms through activation of specific proteolytic cleavage. Mol. Cell. Biol. 1999, 19:1695-1704.
45. Koistinen H., Seppala M., Knuutila S., Koistinen R. Extracellular matrix-induced changes in expression of cell cycle-related proteins and proteasome components in endometrial adenocarcinoma cells. Gynecol. Oncol. 2006, 102:546-551.
46. Qi Y., Xia P. Cellular inhibitor of apoptosis protein-1 (cIAP1) plays a critical role in beta-cell survival under endoplasmic reticulum stress: promoting ubiquitination and degradation of C/EBP homologous protein (CHOP). J. Biol. Chem. 2012, 287:32236-32245.
47. Hattori T., Ohoka N., Inoue Y., Hayashi H., Onozaki K. C/EBP family transcription factors are degraded by the proteasome but stabilized by forming dimer. Oncogene 2003, 22:1273-1280.
48. Voutsadakis I.A. Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Mullerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities. Clin. Transl. Oncol. 2012, 14:243-253.
49. Chen Q.K., Lee K., Radisky D.C., Nelson C.M. Extracellular matrix proteins regulate epithelial-mesenchymal transition in mammary epithelial cells. Differentiation 2013, 86:126-132.
50. Timchenko N.A., Welm A.L., Lu X., Timchenko L.T. CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res. 1999, 27:4517-4525.